Article detail · 2025
New methyl/benzyl‐1,2,4‐triazole‐3‐one Derivatives: Synthesis, Characterization (IR, NMR), Antidiabetic, Anti‐Alzheimer, and Molecular Docking Study
Journal of Biochemical and Molecular Toxicology
- Year
- 2025
- ISSN
1095-6670- Type
- article
Data source split
- YÖKSİS YÖKSİS article record
- OpenAlex OpenAlex enrichment (abstract, citations, topics)
Abstract
English (OpenAlex)
ABSTRACT New 1,2,4‐triazole compounds were synthesized in this study. These compounds (2,3,5,6 (a–f)) were characterized by IR, 1 H‐NMR, and 13 C‐NMR studies. Acarbose was used as a standard for alpha glycosidase and alpha amylase enzymes, while tacrine molecule was used as a standard for acetylcholinesterase enzyme. While the IC 50 result of acarbose was found to be 6.430 ± 0.736, the IC 50 values for α‐gly and α‐amly enzymes were 1.454 ± 0.087 µM–3.7973 ± 0.3352 µM and 1.509 ± 0.161 µM–3.797 ± 0.335 µM, respectively. In addition, the IC 50 values for AChE enzyme were found to be in the range of 1.330 ± 0.118 µM–11.104 ± 3.463 µM. Except for molecules 5a, 5b and 5 f, all other molecules were found to be more active than the standard. Molecular docking simulations were conducted to explore the interactions of 3e and 3 f compounds with Human Acetylcholinesterase, using tacrine as a reference molecule, to evaluate binding affinities and key ligand‐protein interactions.
Topics
- Synthesis and biological activity
- Click Chemistry and Applications
- Synthesis and Characterization of Heterocyclic Compounds
Primary topic Synthesis and biological activity